Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Gut dysbiosis impairs HPA axis function and exacerbates post-stroke inflammation in high-fat diet-fed male mice.

Created on 21 Aug 2026

Authors

Hanlin Zhong, Zeping Jin, Yiqi Liu, Yang Wang, Yunpeng Liu

Published in

Microbiology spectrum. Pages e0354925. Aug 21, 2026. Epub Aug 21, 2026.

Abstract

High-fat diet (HFD)-induced metabolic stress is associated with impaired hypothalamic-pituitary-adrenal (HPA) axis function, but its impact on stroke outcomes and the role of the gut microbiota remain unclear. In a mouse middle cerebral artery occlusion (MCAO) model, we found that HFD induced gut dysbiosis, suppressed hypothalamic CRH expression, and reduced circulating corticosterone, which in turn exacerbated neuroinflammation and neuronal apoptosis, and worsened neurological recovery. Interventions with fecal microbiota transplantation or supplementation of Akkermansia muciniphila partially restored HPA axis activity, mitigated inflammatory injury, and improved behavioral outcomes post-stroke. These findings suggest that a gut microbiota-HPA axis may be relevant under metabolic stress conditions and open a possible microbiota-based adjunctive strategy for improving stroke prognosis in metabolically vulnerable populations.
Metabolic disorders such as obesity and high-fat diet exposure are known to worsen stroke outcomes, but the mechanisms connecting metabolic stress, gut microbiota alterations, and neuroendocrine dysfunction have not been well defined. Our data indicate that gut dysbiosis under HFD conditions is associated with HPA axis suppression and worse neuroinflammatory injury after stroke and that microbiota-targeted intervention can restore hormonal regulation and functional recovery. This highlights the gut microbiota-neuroendocrine interface as a promising area for therapeutic exploration in metabolically at-risk stroke patients.

PMID:
42627161
Bibliographic data and abstract were imported from PubMed on 21 Aug 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 3
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement